XH-5102

N/A

Report date: 2025/08/27 14:48:28
NME

Base Information

Drug NameXH-5102
Drug Alias NameXH-5102XH5102JRF105JRF-105
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitors
TargetsTyrosine-protein kinase JAK2
Therapy Area/IndicationsPrimary MyelofibrosisMyeloproliferative DisordersThrombocythemia, Essential +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Xunhe Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Xunhe Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPrimary MyelofibrosisMyeloproliferative DisordersThrombocythemia, Essential +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A